Compile Data Set for Download or QSAR
Report error Found 30 Enz. Inhib. hit(s) with all data for entry = 7060
TargetProtease(Human immunodeficiency virus type 1)
Purdue Research Foundation

US Patent
LigandChemical structure of BindingDB Monomer ID 171378BDBM171378(US9085571, Table 1, Compound 26)
Affinity DataKi:  0.100nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetProtease(Human immunodeficiency virus type 1)
Purdue Research Foundation

US Patent
LigandChemical structure of BindingDB Monomer ID 171372BDBM171372(US9085571, Table 1, Compound 20)
Affinity DataKi:  0.200nM IC50: 30nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetProtease(Human immunodeficiency virus type 1)
Purdue Research Foundation

US Patent
LigandChemical structure of BindingDB Monomer ID 171370BDBM171370(US9085571, Table 1, Compound 18)
Affinity DataKi:  0.300nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetProtease(Human immunodeficiency virus type 1)
Purdue Research Foundation

US Patent
LigandChemical structure of BindingDB Monomer ID 171353BDBM171353(US9085571, Table 1, Compound 1)
Affinity DataKi:  0.600nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetProtease(Human immunodeficiency virus type 1)
Purdue Research Foundation

US Patent
LigandChemical structure of BindingDB Monomer ID 171354BDBM171354(US9085571, Table 1, Compound 2)
Affinity DataKi:  0.600nM IC50: 20nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetProtease(Human immunodeficiency virus type 1)
Purdue Research Foundation

US Patent
LigandChemical structure of BindingDB Monomer ID 171371BDBM171371(US9085571, Table 1, Compound 19)
Affinity DataKi:  0.600nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetProtease(Human immunodeficiency virus type 1)
Purdue Research Foundation

US Patent
LigandChemical structure of BindingDB Monomer ID 171374BDBM171374(US9085571, Table 1, Compound 22)
Affinity DataKi:  1nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetProtease(Human immunodeficiency virus type 1)
Purdue Research Foundation

US Patent
LigandChemical structure of BindingDB Monomer ID 171380BDBM171380(US9085571, Table 1, Compound 28)
Affinity DataKi:  2nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetProtease(Human immunodeficiency virus type 1)
Purdue Research Foundation

US Patent
LigandChemical structure of BindingDB Monomer ID 171382BDBM171382(US9085571, Table 1, Compound 30)
Affinity DataKi:  4.01nM IC50: 32nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetProtease(Human immunodeficiency virus type 1)
Purdue Research Foundation

US Patent
LigandChemical structure of BindingDB Monomer ID 171365BDBM171365(US9085571, Table 1, Compound 13)
Affinity DataKi:  5nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetProtease(Human immunodeficiency virus type 1)
Purdue Research Foundation

US Patent
LigandChemical structure of BindingDB Monomer ID 171375BDBM171375(US9085571, Table 1, Compound 23)
Affinity DataKi:  5nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetProtease(Human immunodeficiency virus type 1)
Purdue Research Foundation

US Patent
LigandChemical structure of BindingDB Monomer ID 171373BDBM171373(US9085571, Table 1, Compound 21)
Affinity DataKi:  6nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetProtease(Human immunodeficiency virus type 1)
Purdue Research Foundation

US Patent
LigandChemical structure of BindingDB Monomer ID 171367BDBM171367(US9085571, Table 1, Compound 15)
Affinity DataKi:  20nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetProtease(Human immunodeficiency virus type 1)
Purdue Research Foundation

US Patent
LigandChemical structure of BindingDB Monomer ID 171357BDBM171357(US9085571, Table 1, Compound 5)
Affinity DataKi:  20nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetProtease(Human immunodeficiency virus type 1)
Purdue Research Foundation

US Patent
LigandChemical structure of BindingDB Monomer ID 171369BDBM171369(US9085571, Table 1, Compound 17)
Affinity DataKi:  20nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetProtease(Human immunodeficiency virus type 1)
Purdue Research Foundation

US Patent
LigandChemical structure of BindingDB Monomer ID 171381BDBM171381(US9085571, Table 1, Compound 29)
Affinity DataKi:  30nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetProtease(Human immunodeficiency virus type 1)
Purdue Research Foundation

US Patent
LigandChemical structure of BindingDB Monomer ID 171363BDBM171363(US9085571, Table 1, Compound 11)
Affinity DataKi:  40nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetProtease(Human immunodeficiency virus type 1)
Purdue Research Foundation

US Patent
LigandChemical structure of BindingDB Monomer ID 171364BDBM171364(US9085571, Table 1, Compound 12)
Affinity DataKi:  50nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetProtease(Human immunodeficiency virus type 1)
Purdue Research Foundation

US Patent
LigandChemical structure of BindingDB Monomer ID 171376BDBM171376(US9085571, Table 1, Compound 24)
Affinity DataKi:  70nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetProtease(Human immunodeficiency virus type 1)
Purdue Research Foundation

US Patent
LigandChemical structure of BindingDB Monomer ID 171366BDBM171366(US9085571, Table 1, Compound 14)
Affinity DataKi:  100nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetProtease(Human immunodeficiency virus type 1)
Purdue Research Foundation

US Patent
LigandChemical structure of BindingDB Monomer ID 171377BDBM171377(US9085571, Table 1, Compound 25)
Affinity DataKi:  100nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetProtease(Human immunodeficiency virus type 1)
Purdue Research Foundation

US Patent
LigandChemical structure of BindingDB Monomer ID 171361BDBM171361(US9085571, Table 1, Compound 9)
Affinity DataKi:  200nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetProtease(Human immunodeficiency virus type 1)
Purdue Research Foundation

US Patent
LigandChemical structure of BindingDB Monomer ID 171362BDBM171362(US9085571, Table 1, Compound 10)
Affinity DataKi:  200nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetProtease(Human immunodeficiency virus type 1)
Purdue Research Foundation

US Patent
LigandChemical structure of BindingDB Monomer ID 171368BDBM171368(US9085571, Table 1, Compound 16)
Affinity DataKi:  200nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetProtease(Human immunodeficiency virus type 1)
Purdue Research Foundation

US Patent
LigandChemical structure of BindingDB Monomer ID 171360BDBM171360(US9085571, Table 1, Compound 8)
Affinity DataKi:  300nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetProtease(Human immunodeficiency virus type 1)
Purdue Research Foundation

US Patent
LigandChemical structure of BindingDB Monomer ID 171355BDBM171355(US9085571, Table 1, Compound 3)
Affinity DataKi:  300nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetProtease(Human immunodeficiency virus type 1)
Purdue Research Foundation

US Patent
LigandChemical structure of BindingDB Monomer ID 171356BDBM171356(US9085571, Table 1, Compound 4)
Affinity DataKi:  400nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetProtease(Human immunodeficiency virus type 1)
Purdue Research Foundation

US Patent
LigandChemical structure of BindingDB Monomer ID 171379BDBM171379(US9085571, Table 1, Compound 27)
Affinity DataKi:  600nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetProtease(Human immunodeficiency virus type 1)
Purdue Research Foundation

US Patent
LigandChemical structure of BindingDB Monomer ID 171358BDBM171358(US9085571, Table 1, Compound 6)
Affinity DataKi:  1.00E+3nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent

TargetProtease(Human immunodeficiency virus type 1)
Purdue Research Foundation

US Patent
LigandChemical structure of BindingDB Monomer ID 171359BDBM171359(US9085571, Table 1, Compound 7)
Affinity DataKi:  1.00E+3nMAssay Description:Without being bound by theory, it is suggested that the compounds described herein may exert their utility by the inhibition of proteases encoded by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2016
Entry Details
US Patent